Your monthly Udenyca cost savings if eligible
With our assistance, you could access the Udenyca patient assistance program and obtain your medication for free. We only charge a flat monthly fee of $49 per medication for our services.
Am I eligible for Udenyca patient assistance?
We review each Udenyca enrollment application individually to determine if you are eligible. Each assistance program has its own eligibility criteria and the factors considered by most programs are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for the Udenyca patient assistance program?
Our process makes it as easy as possible to apply for the Udenyca patient assistance program. Begin by completing the enrollment application form on our website. Tell us about any medications that you are taking, including Udenyca, your healthcare provider, your insurance plan, and your household income. This information is required by the pharmaceutical manufacturers who will supply the medication, so it is important to make sure this information is accurate and up to date.
We will review the information that you have provided to determine whether you are eligible for patient assistance. If we can pre-qualify you for assistance, NiceRx will handle the full enrollment process on your behalf. If you are approved by the pharmaceutical company, you will typically start receiving your medication in 6 – 8 weeks.
Is NiceRx an Udenyca coupons provider?
NiceRx is not an Udenyca coupon, Udenyca discount card, or Udenyca copay card provider. We do not offer Udenyca manufacturer coupons, Udenyca discounts, rebates, Udenyca savings cards, trial offers, or free Udenyca samples. We are a service provider that helps eligible individuals access their medication directly from the U.S. pharmaceutical company.
Can NiceRx help me if I have insurance?
NiceRx may be able to help you if:
- You have a high copay or coinsurance responsibility for Udenyca
- Your insurance company will not pay for your Udenyca prescription
- Your healthcare plan does not cover your medication
- You do not have insurance
Please apply online to find out if we can help you.
How much does Udenyca cost without insurance?
Without insurance, Udenyca costs will vary depending on where you buy the medication as prices will vary by retailer. As a guide, Udenyca subcutaneous solution (cbqv 6 mg/0.6 mL) will cost around $4,370 for 0.6 milliliters.
How much does Udenyca cost with insurance?
The copay for Udenyca will depend on the terms of your healthcare plan. Your healthcare provider or pharmacist will be able to calculate your copay with your current insurance. Contact them to find out more.
What is Udenyca?
Udenyca is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Coherus BioSciences, Inc. Udenyca stimulates the growth of neutrophils, a type of white blood cell that can become depleted during chemotherapy treatment.
Udenyca is a leukocyte growth factor indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia. Udenyca is not indicated for the mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation.
Udenyca is biosimilar to Neulasta for the indications listed, meaning that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product and that there are no clinically meaningful differences between the biosimilar product and the reference product.
What doses of Udenyca are available?
Udenyca is available in injection form, in the following doses: 6 mg/0.6 mL in a single-dose prefilled syringe.
For patients with cancer receiving myelosuppressive chemotherapy administer 6 mg subcutaneously once per chemotherapy cycle. Do not administer between 14 days before and 24 hours after cytotoxic chemotherapy. Dosing for pediatric patients weighing less than 45 kg should be based on weight.
Please read the patient information guide and always speak with a healthcare professional for medical advice or about any changes to your dose so they can monitor and evaluate your condition.
Udenyca active ingredients
The active ingredient of Udenyca is pegfilgrastim.
Udenyca side effects
The most common side effects of Udenyca in clinical trials include:
- Bone pain and pain in the arms, and legs
In rare instances, Udenyca can cause more serious side effects. These can include:
- Fatal splenic rupture
- Acute respiratory distress syndrome (ARDS) – shortness of breath with or without a fever, trouble breathing, or a fast rate of breathing
- Serious allergic reactions, including anaphylaxis – a rash over your whole body, shortness of breath, wheezing, dizziness, swelling around your mouth or eyes, fast heart rate, and sweating
- Fatal sickle cell crises – you may have a serious sickle cell crisis if you have a sickle cell disorder and receive Udenyca treatment
- Glomerulonephritis – swelling of your face or ankles, blood in your urine or dark-colored urine, urinating less
- Increased white blood cell count (leukocytosis)
- Decreased platelet count (thrombocytopenia)
- Capillary leak syndrome – this can quickly cause you to have symptoms that may become life-threatening. Symptoms include swelling or puffiness and urinating less than usual, trouble breathing, stomach swelling, dizziness or feeling faint, and tiredness
- Increased risk of myelodysplastic syndrome and acute myeloid leukemia (AML) if you have breast cancer or lung cancer when Udenyca is used with chemotherapy and radiation therapy, or with radiation therapy alone
- Inflammation of the aorta (aortitis) – fever, abdominal pain, feeling tired, and back pain
Your doctor will assess the benefits of using Udenyca against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Udenyca to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Udenyca drug interactions
Udenyca can interact with other medications. These include:
- Thalidomide, lenalidomide
- Brentuximab, daratumumab, rituximab
This list is not exhaustive and other prescription drugs may interact with Udenyca. Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
You should not use Udenyca if you:
- Have a history of serious allergic reactions to human granulocyte colony-stimulating factors such as pegfilgrastim or filgrastim
- Are allergic to any of the other ingredients in Udenyca
Talk to your doctor before using Udenyca if you:
- Are taking any of the medications that could interact with Udenyca
- Have sickle cell disorder
- Have kidney disease
- Have chronic myeloid leukemia
- Are having radiation treatment
- Have myelodysplastic syndrome
- Have a latex allergy
- Are pregnant or are planning to become pregnant
- Are breastfeeding or are planning to breastfeed
Udenyca is the trademark brand name for pegfilgrastim-cbqv manufactured by Coherus BioSciences, Inc. A generic version of pegfilgrastim-cbqv is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Udenyca savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.